Screening women with breast MRI based solely on a personal history of breast cancer found malignancies in 12% of the women studied, with a positive predictive value biopsy rate of 39%.
Screening women with breast MRI based solely on a personal history of breast cancer found malignancies in 12% of the women studied, with a positive predictive value biopsy rate of 39%.
A retrospective review of 1699 breast MRI exams performed from 1999 to 2001 yielded 144 women with prior breast cancer who started regular breast MRI screening. Of the 144 women, 31% underwent biopsies prompted by MRI (AJR 2010;195:510-516).
Sixty-one biopsies found 17 carcinomas and one myxoid liposarcoma. The 10 detected by MRI were more likely than the other seven to be ductal carcinoma in situ or node-negative invasive breast cancer <1 cm in size.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.